<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37427773</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2078-6204</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>South African family practice : official journal of the South African Academy of Family Practice/Primary Care</Title><ISOAbbreviation>S Afr Fam Pract (2004)</ISOAbbreviation></Journal><ArticleTitle>Long COVID: An approach to clinical assessment and management in primary care.</ArticleTitle><Pagination><StartPage>e1</StartPage><EndPage>e10</EndPage><MedlinePgn>e1-e10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5751</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.4102/safp.v65i1.5751</ELocationID><Abstract><AbstractText>Long COVID is an emerging public health threat, following swiftly behind the surges of acute infection over the course of the COVID-19 pandemic. It is estimated that there are already approximately 100 million people suffering from Long COVID globally, 0.5 million of whom are South African, and for whom our incomplete understanding of the condition has forestalled appropriate diagnosis and clinical care. There are several leading postulates for the complex, multi-mechanistic pathogenesis of Long COVID. Patients with Long COVID may present with a diversity of clinical phenotypes, often with significant overlap, which may exhibit temporal heterogeneity and evolution. Post-acute care follow-up, targeted screening, diagnosis, a broad initial assessment and more directed subsequent assessments are necessary at the primary care level. Symptomatic treatment, self-management and rehabilitation are the mainstays of clinical care for Long COVID. However, evidence-based pharmacological interventions for the prevention and treatment of Long COVID are beginning to emerge. This article presents a rational approach for assessing and managing patients with Long COVID in the primary care setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perumal</LastName><ForeName>Rubeshan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa, Faculty of Medicine, University of KwaZulu-Natal, Durban, South Africa; and Department of Pulmonology, Faculty of Medicine, University of KwaZulu-Natal, Durban. rubeshanperumal@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shunmugam</LastName><ForeName>Letitia</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Naidoo</LastName><ForeName>Kogieleum</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_16022</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>South Africa</Country><MedlineTA>S Afr Fam Pract (2004)</MedlineTA><NlmUniqueID>9701104</NlmUniqueID><ISSNLinking>2078-6190</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2.</Keyword><Keyword MajorTopicYN="N">long-haul COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37427773</ArticleId><ArticleId IdType="pmc">PMC10331047</ArticleId><ArticleId IdType="doi">10.4102/safp.v65i1.5751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al. . Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One. 2022;17(12):e0278825. 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, et al. . Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. Brit Med J. 2023;380:e072529. 10.1136/bmj-2022-072529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. . Long COVID in the Faroe Islands: A longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73(11):e4058&#x2013;e4063. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T, Hanson SW, Abbafati C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. J Am Med Assoc. 2022;328(16):1604&#x2013;1615. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, et al. . A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102&#x2013;111. 10.1016/j.ijid.2022.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId><ArticleId IdType="pmc">PMC9800016</ArticleId><ArticleId IdType="pubmed">36587841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-Coronavirus Disease 2019 (COVID-19) condition or Long COVID: A meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Zhang L, Elb&#xe9;ji A, et al. . Long COVID symptomatology after 12 months and its impact on Quality of Life according to initial Coronavirus Disease 2019 disease severity. Open Forum Infect Dis. 2022;9(8):ofac397. 10.1093/ofid/ofac397</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KGI, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. J Am Med Assoc. 2021;325(15):1525&#x2013;1534. 10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220&#x2013;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, et al. . Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. 2021;10(11):1408. 10.3390/pathogens10111408</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health . Patients diagnosed with post-COVID conditions: An analysis of private healthcare claims using the official ICD-10 diagnostic code. 2022. 
[cited 2023 May 27]. Available from: https://www.fairhealth.org/article/fair-health-releases-study-on-post-covid-conditions</Citation></Reference><Reference><Citation>Bygdell M, Leach S, Lundberg L, et al. . A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the International Classification of Diseases Tenth Revision diagnosis code (U09.9): A population-based cohort study. Int J Infect Dis. 2023;126:104&#x2013;113. 10.1016/j.ijid.2022.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.021</ArticleId><ArticleId IdType="pmc">PMC9678230</ArticleId><ArticleId IdType="pubmed">36410693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bitna-Ha, Kim SW, et al. . Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22(1):1&#x2013;12. 10.1186/s12879-022-07062-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1&#x2013;6. 10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, et al. . Factors associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;2:1&#x2013;8. 10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Brito-Zer&#xf3;n P, Ferr&#xed;n LC, et al. . Long covid-19: Proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350. 10.3390/ijerph18084350</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, et al. . Identification of distinct Long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9(4): ofac060. 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Mangion K. Multisystem involvement is common in post-COVID-19 syndrome. Nat Med. 2022;28(6):1139&#x2013;1140. 10.1038/s41591-022-01838-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01838-8</ArticleId><ArticleId IdType="pmc">PMC9125959</ArticleId><ArticleId IdType="pubmed">35606552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds. Brit Med J. 2022;378:o1838. 10.1136/bmj.o1838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1838</ArticleId><ArticleId IdType="pubmed">35868645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, et al. . Long COVID: The nature of thrombotic sequelae determines the necessity of early anticoagulation. Front 2022;12:408. 10.3389/fcimb.2022.861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, et al. . Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Front. 2022;3(6):371. 10.3389/fcimb.2022.861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315. 10.1002/rmv.2315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Larsen N, Muppidi S. Inappropriate sinus tachycardia in long-COVID and other updates on recent autonomic research. Clin Auton Res. 2022;32(2):91&#x2013;94. 10.1007/s10286-022-00854-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-022-00854-5</ArticleId><ArticleId IdType="pubmed">35129713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l EK, Harbo T, Agergaard J, et al. . Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29(9):2832&#x2013;2841 10.1111/ene.15435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Zhang S, Porritt RA, et al. . Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci USA. 2020;117(41):25254&#x2013;25262. 10.1073/pnas.2010722117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537. 10.1073/pnas.2010722117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Venter C, Vlok M, et al. . SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci Rep. 2021;41(8):20210611. 10.1042/BSR20210611</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu ML, Liu FL, Sun J, et al. . SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct Target Ther. 2021;6(1):1&#x2013;15. 10.1042/BSR20210611</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8677926</ArticleId><ArticleId IdType="pubmed">34921131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann C, Miggiolaro AFR dos S, Motta J da S, et al. . The pathogenesis of COVID-19 myocardial injury: An immunohistochemical study of postmortem biopsies. Front Immunol. 2021;12:4624. 10.3389/fimmu.2021.748417</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748417</ArticleId><ArticleId IdType="pmc">PMC8602833</ArticleId><ArticleId IdType="pubmed">34804033</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J Investig Med. 2022. [cited 2023 Mar 20];70(1):61&#x2013;67. 10.1136/jim-2021-002051</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217. 10.1016/j.ijid.2021.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61(1):2200970. 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenazy MF, Aljohar HI, Alruwaili AR, et al. . Gut microbiota dynamics in relation to Long-COVID-19 syndrome: Role of probiotics to combat psychiatric complications. Metabolites. 2022;12(10):912. 10.3390/metabo12100912</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12100912</ArticleId><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="pubmed">36295814</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Lau RI, Liu Q, Chan FKL, Ng SC. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance. Gut. 2022;72(6):1230&#x2013;1232. 10.1136/gutjnl-2022-328319</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-328319</ArticleId><ArticleId IdType="pubmed">35940857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42(9):1523&#x2013;1530. 10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in Long COVID. Viruses. 2023;15(2):400. 10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer PE, Kirwan JP, Rosen CJ. Post-acute sequelae of COVID-19: A metabolic perspective. Elife. 2022;11:78200. 10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezhnoy G, Bissinger R, Liu A, et al. . Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome (LTCS) patients. Front. Immunol. 2023;14. 10.3389/fimmu.2023.1144224</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1144224</ArticleId><ArticleId IdType="pmc">PMC10203989</ArticleId><ArticleId IdType="pubmed">37228606</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol. 2022;76:102608. 10.1016/j.conb.2022.102608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2022.102608</ArticleId><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452. 10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich HG, et al. . Post-acute sequelae of covid-19 six to 12 months after infection: Population based study. Brit Med J. 2022;379: 102608. 10.1016/j.conb.2022.102608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2022.102608</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J, Buck P, Zipfel S, Stengel A. Post-COVID-19 fatigue: A systematic review. Front Psychiatry. 2022;13: 947973. 10.3389/fpsyt.2022.947973</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintschich CA, Fischer R, Hummel T, Wenzel JJ, Bohr C, Vielsmeier V. Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection. PLoS One. 2022;17(3):e0265686. 10.1371/journal.pone.02656860020</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.02656860020</ArticleId><ArticleId IdType="pmc">PMC8942205</ArticleId><ArticleId IdType="pubmed">35320821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a long-term sequela of COVID-19. SN Compr Clin Med. 2023;5(1):9. 10.1371/journal.pone.0265686</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265686</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41(1):289. 10.1007/s10067-021-05942-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes Z, Courtney A, Lincoln M, Weller R. Rash morphology as a predictor of COVID-19 severity: A systematic review of the cutaneous manifestations of COVID-19. Skin Health and Dis. 2022;2(3):e120. 10.1002/ski2.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ski2.120</ArticleId><ArticleId IdType="pmc">PMC9348185</ArticleId><ArticleId IdType="pubmed">35941938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogariu AM, Dumitrascu DL. Digestive involvement in the Long-COVID syndrome. Med Pharm Rep. 2022;95(1):5&#x2013;10. 10.15386/mpr-2340</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-2340</ArticleId><ArticleId IdType="pmc">PMC9177081</ArticleId><ArticleId IdType="pubmed">35720240</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. 10.1002/ski2.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ski2.120</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. 10.1002/ski2.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ski2.120</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32(11):2851&#x2013;2862. 10.1681/ASN.2021060734</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;2415. 10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Discovery Health Medical Scheme . Prescribed minimum benefits basket of care for who global outbreak benefit; 2021. 
[cited 2023 May 27]. Available from: https://www.discovery.co.za/wcm/discoverycoza/assets/medical-aid/benefit-information/2021/who-global-outbreak-benefit-basket-of-care-august-2021.pdf</Citation></Reference><Reference><Citation>Ministerial Advisory Committee (MAC) on COVID-19 . Diagnosis, treatment and management of Long COVID. South Africa: Department of Health; 2022. 
[cited 2023 may 27]. Available from: https://sacoronavirus.co.za/wp-content/uploads/2022/06/MAC-on-COVID-19_Advisory-on-Long-COVID_27May22_final.pdf</Citation></Reference><Reference><Citation>Van Zyl-Smit R, Feldman C, Richards G, et al. . South African Thoracic Society statement on obstructive airways disease and COVID-19. Afr J Thora Crit Care Med. 2020;26(3):117&#x2013;118. 10.7196/ajtccm.2020.v26i3.111</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/ajtccm.2020.v26i3.111</ArticleId><ArticleId IdType="pmc">PMC8397166</ArticleId><ArticleId IdType="pubmed">34476396</ArticleId></ArticleIdList></Reference><Reference><Citation>South African National Department of Health: Clinical Management Guidelines for COVID-19 . Module 11: Long-COVID/Post-Acute Sequelae of COVID (PASC); 2021. 
[cited 2023 May 27]. Available from: https://www.nicd.ac.za/wp-content/uploads/2021/03/11-Long-COVID.pdf</Citation></Reference><Reference><Citation>Mikkelsen ME, Abramoff B. COVID-19: Evaluation and management of adults with persistent symptoms following acute illness (&#x2018;Long COVID&#x2019;) [homepage on the Internet]. In: Post TW, editor. UpToDate, Inc., 2023. 
[cited 2023 May 27]. Available from: https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-with-persistent-symptoms-following-acute-illness-long-covid</Citation></Reference><Reference><Citation>World Health Organization . Clinical management of COVID-19: Living guideline, 15 September 2022 [homepage on the Internet]. 2022. 
[cited 2023 Mar 21]. Available from: https://apps.who.int/iris/handle/10665/362783</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. Brit Med J. 2021;372:n136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, et al. . ESCMID rapid guidelines for assessment and management of long COVID. Clinical Microbiology and Infection 2022;28(7):955&#x2013;972. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M, Rayner C, Freyer A, et al. . Recommendations for the recognition, diagnosis, and management of long COVID: A Delphi study. Br J Gen Pract. 2021;71(712):e815&#x2013;e825. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . COVID-19 rapid guideline: Managing COVID-19. NICE; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34181371</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022 28:11. 2022;28(11):2398&#x2013;2405. 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Nirmatrelvir and the risk of Post-Acute Sequelae of COVID-19. medRxiv. Preprint 2022. 10.1101/2022.11.03.22281783</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.03.22281783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz D, et al. . Outpatient treatment of COVID-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up. medRxiv. Preprint 2022. 10.1101/2022.12.21.22283753</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.21.22283753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E, Barile Agati L, Calderaro D, et al. . Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): An open-label, multicentre, randomised, controlled trial. Lancet. 2022;399(10319):50&#x2013;59. 10.1016/S0140-6736(21)02392-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>